When I was pregnant with Jasper I made the decision to stop receiving treatment for my MS. Weighing up the risks vs benefits was tricky. Ultimately, I made the call to put the health of my baby first. I knew the risks of harm to him were minimal, unknown and quite possibly non-existent.
The drive to put your unborn baby first is very powerful. I expect all expectant mothers feel this way.
I’m now faced with the same decision. Do I stop treatment, increasing my risk of relapse? Do I continue treatment, with the unknown harm this may or may not cause my baby. I read countless articles, watch a video from a neuroscience research fellow, and talk to neurology health professionals. There are no definitive answers.
“If a woman becomes pregnant while taking TYSABRI, discontinuation of therapy should be considered. A benefit-risk evaluation of the use of natalizumab during pregnancy should take into account the patient’s clinical condition and the possible return of disease activity after stopping the
medicinal product.”
I make the call to stop treatment and hope that I stay well.
